Highest-materiality recent filing
Tenet Q1 GAAP EPS $8.01, adj EPS $4.82 beats; Ambulatory EBITDA up 6.1%
Net income available to common shareholders $702M ($8.01 diluted EPS); adjusted diluted EPS $4.82 vs $4.36 YoY.
Tenet Q4 2025 adjusted EPS $4.70, up 36.6% YoY; FY2026 EBITDA guidance $4.485-$4.785B
Q4 net income $371M ($4.22 diluted EPS); adjusted EPS $4.70 vs $3.44 YoY; revenue $5.527B (+9% YoY).
Tenet announces $1.9B CommonSpirit deal; 2025 Adj. EBITDA at upper end of guidance
CommonSpirit to pay Tenet $1.9B over 3 years; Tenet redeems CommonSpirit's 23.8% Conifer equity for $540M.
Tenet issues $2.25B in notes to refinance near-term debt maturities
Issued $1.5B of 5.500% senior secured first lien notes due 2032 and $750M of 6.000% senior notes due 2033.
Tenet Healthcare prices $2.25B notes offering; upsized senior notes to 6.00% due 2033
Offering: $1.5B 5.500% first lien notes due 2032 and $0.75B 6.000% senior notes due 2033 (upsized from $0.5B).
Tenet Q3 adjusted EPS $3.70 beats $2.93 YoY; raises FY2025 EBITDA outlook
Net income $342M ($3.86 diluted); adjusted EPS $3.70, up 26.3% YoY from $2.93.
Tenet Q2 adjusted EPS $4.02 (+74% YoY); raises FY 2025 EBITDA outlook to $4.40-$4.54B
Q2 2025 net income $288M, $3.14 diluted EPS; adjusted diluted EPS $4.02 vs $2.31 in Q2 2024.
Tenet Healthcare promotes Lisa Y. Foo to Chief Operating Officer (newly created role)
Lisa Y. Foo named COO effective May 30, 2025; position is newly created.
On May 30, 2025 , Lisa Y. Foo was promoted to Chief Operating Officer of Tenet Healthcare Corporation (the “Company”), a newly created position within the Company, effective immediately.
Max materiality 0.85 · Median 0.60 · Most common event earnings